Optimal therapy for multidrug-resistant tuberculosis and HIV

Lancet. 2020 Aug 8;396(10248):363-365. doi: 10.1016/S0140-6736(20)31688-3.

Authors

Harriet Mayanja-Kizza¹, Christine Sekaggya-Wiltshire², Desta Kassa³

Affiliations

¹ Department of Medicine, Makerere University, Kampala, Uganda. Electronic address: hmk@chs.mak.ac.ug.
² Department of Medicine, Makerere University, Kampala, Uganda.
³ HIV/AIDS and TB Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

PMID: 32771093
DOI: 10.1016/S0140-6736(20)31688-3

No abstract available

Publication types

Comment

MeSH terms

Adult
HIV Infections*
Humans
Tuberculosis*
Tuberculosis, Multidrug-Resistant*